ClinicalTrials.Veeva

Menu

Evaluation of Novel Cardio-Pulmonary Physiological Monitor, the VQm PHM™, for Acute Care Medicine

R

Rostrum Medical Innovations

Status

Unknown

Conditions

Elective Procedures Requiring Mechanical Ventilation

Treatments

Device: VQm PHM™

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04730063
1685958-2

Details and patient eligibility

About

This is a prospective, observational study to assess agreement of pulmonary health parameters measured by a new non-invasive physiologic monitor, the VQm pulmonary health monitor (PHM)™ with clinical gold standards.

Full description

The specific aim of this study is to evaluate the intermittent non-invasive measurements of pulmonary function: pulmonary blood flow (PBF), functional residual capacity (FRC), shunt fraction index (Qsi) and airway dead space measured by the VQm PHM™ compared to known clinical standards. PBF will be compared to continuous and intermittent bolus thermodilution cardiac output as measured through a Swan-Ganz catheter. FRC will be compared to an FRC measurement provided by a standard nitrogen washout method. Qsi will be compared to shunt fraction calculated through mixed venous and arterial blood gas values (VBGs/ABGs). Airway dead space will be compared to an airway dead space measurement provided by a ventilator.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age greater than 18 years
  • Scheduled for an elective surgical procedure with an anticipated duration of more than 2 hours requiring general anesthesia without the use of inhalation anesthetics
  • Surgical procedure that requires pressure-controlled positive pressure ventilation using an endotracheal tube
  • Surgical procedure that requires the use of intra-arterial pressure monitoring and/or a Swan-Ganz catheter for the monitoring of continuous cardiac output

Exclusion criteria

  • Patients who require ventilation tidal volumes less than 250cc
  • Age less than 18 years
  • Pregnancy
  • Prisoners
  • Surgical procedure which requires carbon dioxide (CO2) insufflation
  • Unable to tolerate a transient increase in inhaled CO2
  • Unable to tolerate a transient increase in inhaled nitrous oxide (N2O) or use of N2O is contraindicated
  • Patients who require a high fraction of inspired oxygen (FiO2) (>70%) to maintain a hemoglobin saturation (SpO2>98%)

Women, minorities or non-English speaking subjects will not be excluded

Trial contacts and locations

1

Loading...

Central trial contact

Nathan Ayoubi, BSc; Neal W Fleming, M.D., Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems